Clonidine restores pressor responsiveness to phenylephrine and angiotensin II in ovine sepsis

Yugeesh R Lankadeva, Lindsea C Booth, Junko Kosaka, Roger G Evans, Luc Quintin, Rinaldo Bellomo, Clive N May

Research output: Contribution to journalArticleResearchpeer-review

38 Citations (Scopus)


OBJECTIVES: In sepsis, prolonged, sympathetic overstimulation may lead to vasopressor-refractory hypotension. We therefore examined the effects of the alpha2-adrenergic agonist clonidine on mean arterial pressure, renal sympathetic nerve activity, and pressor responsiveness to phenylephrine and angiotensin II during hypotensive sepsis in conscious sheep. DESIGN: Interventional study. SETTING: Research institute. SUBJECTS: Twelve adult Merino ewes (n = 6 per group). INTERVENTIONS: Sepsis was induced by IV infusion of Escherichia coli for 32 hours. Pressor responses to increasing doses of phenylephrine and angiotensin II were measured at baseline and at 24, 28, and 32 hours of sepsis. Sheep were treated with clonidine (1 mug/kg/hr) or saline-vehicle from 24 to 32 hours of sepsis. MEASUREMENTS AND MAIN RESULTS: Sepsis was characterized by hypotension ( 12 mm Hg), increased heart rate ( 80 beats/min), increased renal sympathetic nerve activity ( 70 ), and blunted pressor responses to phenylephrine and angiotensin II. In vehicle-treated sheep, mean arterial pressure progressively declined from 25 to 32 hours of sepsis (73 +/- 3 to 66 +/- 3 mm Hg; p = 0.013) while the elevations in heart rate and renal sympathetic nerve activity and reduced pressor responsiveness to vasopressors persisted. Clonidine treatment prevented the further decline in mean arterial pressure, substantially reduced heart rate and renal sympathetic nerve activity and restored pressor responsiveness to both phenylephrine and angiotensin II toward preseptic levels. CONCLUSIONS: Administration of clonidine during hypotensive sepsis reduced renal sympathetic nerve activity, restored vascular sensitivity to both phenylephrine and angiotensin II, and resulted in better preservation of arterial pressure. Considering these findings, a clinical trial for the use of clonidine in the treatment of persistent vasopressor-refractory hypotension in patients with septic shock would be worthwhile.
Original languageEnglish
Pages (from-to)221 - 229
Number of pages9
JournalCritical Care Medicine
Issue number7
Publication statusPublished - 2015

Cite this